Global Biopharmaceuticals Contract Manufacturing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biopharmaceuticals Contract Manufacturing Market Research Report 2024
Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
According to Mr Accuracy reports’s new survey, global Biopharmaceuticals Contract Manufacturing market is projected to reach US$ 120590 million in 2034, increasing from US$ 87830 million in 2024, with the CAGR of 4.7% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharmaceuticals Contract Manufacturing market research.
Key companies engaged in the Biopharmaceuticals Contract Manufacturing industry include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma, JRS Pharma, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies and Toyobo Co., Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Biopharmaceuticals Contract Manufacturing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Biopharmaceuticals Contract Manufacturing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceuticals Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
Segment by Type
Biologics
Biosimilars
Process Development
Packaging
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biopharmaceuticals Contract Manufacturing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Biopharmaceuticals Contract Manufacturing market is projected to reach US$ 120590 million in 2034, increasing from US$ 87830 million in 2024, with the CAGR of 4.7% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharmaceuticals Contract Manufacturing market research.
Key companies engaged in the Biopharmaceuticals Contract Manufacturing industry include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma, JRS Pharma, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies and Toyobo Co., Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Biopharmaceuticals Contract Manufacturing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Biopharmaceuticals Contract Manufacturing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceuticals Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Boehringer Ingelheim
Lonza Group AG
Inno Biologics Sdn Bhd
Rentschler Biopharma
JRS Pharma
AGC Biologics
ProBioGen
FUJIFILM Diosynth Biotechnologies
Toyobo Co., Ltd.
Samsung Biologics
Thermo Fisher Scientific
Binex Co., Ltd.
WuXi Biologics
AbbVie, Inc.
Segment by Type
Biologics
Biosimilars
Segment by Application
Process Development
Packaging
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Biopharmaceuticals Contract Manufacturing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source